Report Detail

Service & Software Global EMEA Sterility Testing Market Insights, Forecast to 2028

  • RnM4486216
  • |
  • 24 August, 2022
  • |
  • Global
  • |
  • 96 Pages
  • |
  • QYResearch
  • |
  • Service & Software

Description:
Report Overview

Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for EMEA Sterility Testing estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028.

The USA market for EMEA Sterility Testing is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.

The China market for EMEA Sterility Testing is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.

The Europe market for EMEA Sterility Testing is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.

The global key companies of EMEA Sterility Testing include BioMerieux SA, SGS SA, Thermo Fisher Scientific Inc., Danaher, Merck KGaA, Nelson Laboratories, LLC, TOXIKON, WuXiAppTec and Rapid Micro Biosystems, Inc., etc. In 2021, the global top five players had a share approximately % in terms of revenue.

Report Scope

This latest report researches the industry structure, revenue and gross margin. Major players’ headquarters, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the EMEA Sterility Testing companies, distributors, end users, industry associations, governments' industry bureaus, industry publications, industry experts, third party database, and our in-house databases.

This report also includes a discussion of the major players across each regional EMEA Sterility Testing market. Further, it explains the major drivers and regional dynamics of the global EMEA Sterility Testing market and current trends within the industry.

Key Companies Covered

In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable revenue, market share and rank data of the companies for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:

BioMerieux SA

SGS SA

Thermo Fisher Scientific Inc.

Danaher

Merck KGaA

Nelson Laboratories, LLC

TOXICONE

WuXiAppTec

Rapid Micro Biosystems, Inc.

Baxter

Pace Analytical

Market Segments

This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides revenue forecast data by type and by application segments based on value for the period 2017-2028.

EMEA Sterility Testing Segment by Type

Membrane Filtration

Fluid Path Sterility Testing

Direct Inoculation

Others

EMEA Sterility Testing Segment by Application

Medical Device Manufacturers

Pharmaceutical & Biological Manufacturers

Key Regions & Countries

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value data of each region and country for the period 2017-2028.

North America

United States

Canada

Europe

Germany

France

UK

Italy

Russia

Nordic Countries

Rest of Europe

Asia-Pacific

China

Japan

South Korea

Southeast Asia

India

Australia

Rest of Asia

Latin America

Mexico

Brazil

Rest of Latin America

Middle East & Africa

Turkey

Saudi Arabia

UAE

Rest of MEA

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

COVID-19 and Russia-Ukraine War Influence Analysis

The readers in the section will understand how the EMEA Sterility Testing market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Report Includes:

This report presents an overview of global market for EMEA Sterility Testing market size. Analyses of the global market trends, with historic market revenue data for 2017 - 2021, estimates for 2022, and projections of CAGR through 2028.

This report researches the key producers of EMEA Sterility Testing, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for EMEA Sterility Testing, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the EMEA Sterility Testing revenue, market share and industry ranking of main companies, data from 2017 to 2022. Identification of the major stakeholders in the global EMEA Sterility Testing market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by type and by application, revenue, and growth rate, from 2017 to 2028. Evaluation and forecast the market size for EMEA Sterility Testing revenue, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including BioMerieux SA, SGS SA, Thermo Fisher Scientific Inc., Danaher, Merck KGaA, Nelson Laboratories, LLC, TOXIKON, WuXiAppTec and Rapid Micro Biosystems, Inc., etc.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Revenue of EMEA Sterility Testing in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of EMEA Sterility Testing companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments according to product types, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments according to application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: North America by type, by application and by country, revenue for each segment.

Chapter 7: Europe by type, by application and by country, revenue for each segment.

Chapter 8: Asia Pacific by type, by application and by country/region, revenue for each segment.

Chapter 9: Latin America by type, by application and by country, revenue for each segment.

Chapter 10: Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, EMEA Sterility Testing revenue, gross margin, and recent development, etc.

Chapter 12: Analyst's Viewpoints/Conclusions


Table of content:

    1 Report Business Overview

    • 1.1 Study Scope
    • 1.2 Market Analysis by Type
    • 1.2.1 Global EMEA Sterility Testing Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
  • 1.2.2 Membrane Filtration
  • 1.2.3 Fluid Path Sterility Testing
  • 1.2.4 Direct Inoculation
  • 1.2.5 Others
  • 1.3 Market by Application
  • 1.3.1 Global EMEA Sterility Testing Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
  • 1.3.2 Medical Device Manufacturers
  • 1.3.3 Pharmaceutical & Biological Manufacturers
  • 1.4 Study Objectives
  • 1.5 Years Considered
  • 2 Global Growth Trends

    • 2.1 Global EMEA Sterility Testing Market Perspective (2017-2028)
    • 2.2 EMEA Sterility Testing Growth Trends by Region
    • 2.2.1 EMEA Sterility Testing Market Size by Region: 2017 VS 2021 VS 2028
  • 2.2.2 EMEA Sterility Testing Historic Market Size by Region (2017-2022)
  • 2.2.3 EMEA Sterility Testing Forecasted Market Size by Region (2023-2028)
  • 2.3 EMEA Sterility Testing Market Dynamics
  • 2.3.1 EMEA Sterility Testing Industry Trends
  • 2.3.2 EMEA Sterility Testing Market Drivers
  • 2.3.3 EMEA Sterility Testing Market Challenges
  • 2.3.4 EMEA Sterility Testing Market Restraints
  • 3 Competition Landscape by Key Players

    • 3.1 Global Top EMEA Sterility Testing Players by Revenue
    • 3.1.1 Global Top EMEA Sterility Testing Players by Revenue (2017-2022)
  • 3.1.2 Global EMEA Sterility Testing Revenue Market Share by Players (2017-2022)
  • 3.2 Global EMEA Sterility Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
  • 3.3 Players Covered: Ranking by EMEA Sterility Testing Revenue
  • 3.4 Global EMEA Sterility Testing Market Concentration Ratio
  • 3.4.1 Global EMEA Sterility Testing Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Top 10 and Top 5 Companies by EMEA Sterility Testing Revenue in 2021
  • 3.5 EMEA Sterility Testing Key Players Head office and Area Served
  • 3.6 Key Players EMEA Sterility Testing Product Solution and Service
  • 3.7 Date of Enter into EMEA Sterility Testing Market
  • 3.8 Mergers & Acquisitions, Expansion Plans
  • 4 EMEA Sterility Testing Breakdown Data by Type

    • 4.1 Global EMEA Sterility Testing Historic Market Size by Type (2017-2022)
    • 4.2 Global EMEA Sterility Testing Forecasted Market Size by Type (2023-2028)

    5 EMEA Sterility Testing Breakdown Data by Application

    • 5.1 Global EMEA Sterility Testing Historic Market Size by Application (2017-2022)
    • 5.2 Global EMEA Sterility Testing Forecasted Market Size by Application (2023-2028)

    6 North America

    • 6.1 North America EMEA Sterility Testing Market Size (2017-2028)
    • 6.2 North America EMEA Sterility Testing Market Size by Type
    • 6.2.1 North America EMEA Sterility Testing Market Size by Type (2017-2022)
  • 6.2.2 North America EMEA Sterility Testing Market Size by Type (2023-2028)
  • 6.2.3 North America EMEA Sterility Testing Market Share by Type (2017-2028)
  • 6.3 North America EMEA Sterility Testing Market Size by Application
  • 6.3.1 North America EMEA Sterility Testing Market Size by Application (2017-2022)
  • 6.3.2 North America EMEA Sterility Testing Market Size by Application (2023-2028)
  • 6.3.3 North America EMEA Sterility Testing Market Share by Application (2017-2028)
  • 6.4 North America EMEA Sterility Testing Market Size by Country
  • 6.4.1 North America EMEA Sterility Testing Market Size by Country (2017-2022)
  • 6.4.2 North America EMEA Sterility Testing Market Size by Country (2023-2028)
  • 6.4.3 United States
  • 6.4.4 Canada
  • 7 Europe

    • 7.1 Europe EMEA Sterility Testing Market Size (2017-2028)
    • 7.2 Europe EMEA Sterility Testing Market Size by Type
    • 7.2.1 Europe EMEA Sterility Testing Market Size by Type (2017-2022)
  • 7.2.2 Europe EMEA Sterility Testing Market Size by Type (2023-2028)
  • 7.2.3 Europe EMEA Sterility Testing Market Share by Type (2017-2028)
  • 7.3 Europe EMEA Sterility Testing Market Size by Application
  • 7.3.1 Europe EMEA Sterility Testing Market Size by Application (2017-2022)
  • 7.3.2 Europe EMEA Sterility Testing Market Size by Application (2023-2028)
  • 7.3.3 Europe EMEA Sterility Testing Market Share by Application (2017-2028)
  • 7.4 Europe EMEA Sterility Testing Market Size by Country
  • 7.4.1 Europe EMEA Sterility Testing Market Size by Country (2017-2022)
  • 7.4.2 Europe EMEA Sterility Testing Market Size by Country (2023-2028)
  • 7.4.3 Germany
  • 7.4.4 France
  • 7.4.5 U.K.
  • 7.4.6 Italy
  • 7.4.7 Russia
  • 7.4.8 Nordic Countries
  • 8 Asia-Pacific

    • 8.1 Asia-Pacific EMEA Sterility Testing Market Size (2017-2028)
    • 8.2 Asia-Pacific EMEA Sterility Testing Market Size by Type
    • 8.2.1 Asia-Pacific EMEA Sterility Testing Market Size by Type (2017-2022)
  • 8.2.2 Asia-Pacific EMEA Sterility Testing Market Size by Type (2023-2028)
  • 8.2.3 Asia-Pacific EMEA Sterility Testing Market Share by Type (2017-2028)
  • 8.3 Asia-Pacific EMEA Sterility Testing Market Size by Application
  • 8.3.1 Asia-Pacific EMEA Sterility Testing Market Size by Application (2017-2022)
  • 8.3.2 Asia-Pacific EMEA Sterility Testing Market Size by Application (2023-2028)
  • 8.3.3 Asia-Pacific EMEA Sterility Testing Market Share by Application (2017-2028)
  • 8.4 Asia-Pacific EMEA Sterility Testing Market Size by Region
  • 8.4.1 Asia-Pacific EMEA Sterility Testing Market Size by Region (2017-2022)
  • 8.4.2 Asia-Pacific EMEA Sterility Testing Market Size by Region (2023-2028)
  • 8.4.3 China
  • 8.4.4 Japan
  • 8.4.5 South Korea
  • 8.4.6 Southeast Asia
  • 8.4.7 India
  • 8.4.8 Australia
  • 9 Latin America

    • 9.1 Latin America EMEA Sterility Testing Market Size (2017-2028)
    • 9.2 Latin America EMEA Sterility Testing Market Size by Type
    • 9.2.1 Latin America EMEA Sterility Testing Market Size by Type (2017-2022)
  • 9.2.2 Latin America EMEA Sterility Testing Market Size by Type (2023-2028)
  • 9.2.3 Latin America EMEA Sterility Testing Market Share by Type (2017-2028)
  • 9.3 Latin America EMEA Sterility Testing Market Size by Application
  • 9.3.1 Latin America EMEA Sterility Testing Market Size by Application (2017-2022)
  • 9.3.2 Latin America EMEA Sterility Testing Market Size by Application (2023-2028)
  • 9.3.3 Latin America EMEA Sterility Testing Market Share by Application (2017-2028)
  • 9.4 Latin America EMEA Sterility Testing Market Size by Country
  • 9.4.1 Latin America EMEA Sterility Testing Market Size by Country (2017-2022)
  • 9.4.2 Latin America EMEA Sterility Testing Market Size by Country (2023-2028)
  • 9.4.3 Mexico
  • 9.4.4 Brazil
  • 10 Middle East & Africa

    • 10.1 Middle East & Africa EMEA Sterility Testing Market Size (2017-2028)
    • 10.2 Middle East & Africa EMEA Sterility Testing Market Size by Type
    • 10.2.1 Middle East & Africa EMEA Sterility Testing Market Size by Type (2017-2022)
  • 10.2.2 Middle East & Africa EMEA Sterility Testing Market Size by Type (2023-2028)
  • 10.2.3 Middle East & Africa EMEA Sterility Testing Market Share by Type (2017-2028)
  • 10.3 Middle East & Africa EMEA Sterility Testing Market Size by Application
  • 10.3.1 Middle East & Africa EMEA Sterility Testing Market Size by Application (2017-2022)
  • 10.3.2 Middle East & Africa EMEA Sterility Testing Market Size by Application (2023-2028)
  • 10.3.3 Middle East & Africa EMEA Sterility Testing Market Share by Application (2017-2028)
  • 10.4 Middle East & Africa EMEA Sterility Testing Market Size by Country
  • 10.4.1 Middle East & Africa EMEA Sterility Testing Market Size by Country (2017-2022)
  • 10.4.2 Middle East & Africa EMEA Sterility Testing Market Size by Country (2023-2028)
  • 10.4.3 Turkey
  • 10.4.4 Saudi Arabia
  • 10.4.5 UAE
  • 11 Key Players Profiles

    • 11.1 BioMerieux SA
    • 11.1.1 BioMerieux SA Company Details
  • 11.1.2 BioMerieux SA Business Overview
  • 11.1.3 BioMerieux SA EMEA Sterility Testing Introduction
  • 11.1.4 BioMerieux SA Revenue in EMEA Sterility Testing Business (2017-2022)
  • 11.1.5 BioMerieux SA Recent Developments
  • 11.2 SGS SA
  • 11.2.1 SGS SA Company Details
  • 11.2.2 SGS SA Business Overview
  • 11.2.3 SGS SA EMEA Sterility Testing Introduction
  • 11.2.4 SGS SA Revenue in EMEA Sterility Testing Business (2017-2022)
  • 11.2.5 SGS SA Recent Developments
  • 11.3 Thermo Fisher Scientific Inc.
  • 11.3.1 Thermo Fisher Scientific Inc. Company Details
  • 11.3.2 Thermo Fisher Scientific Inc. Business Overview
  • 11.3.3 Thermo Fisher Scientific Inc. EMEA Sterility Testing Introduction
  • 11.3.4 Thermo Fisher Scientific Inc. Revenue in EMEA Sterility Testing Business (2017-2022)
  • 11.3.5 Thermo Fisher Scientific Inc. Recent Developments
  • 11.4 Danaher
  • 11.4.1 Danaher Company Details
  • 11.4.2 Danaher Business Overview
  • 11.4.3 Danaher EMEA Sterility Testing Introduction
  • 11.4.4 Danaher Revenue in EMEA Sterility Testing Business (2017-2022)
  • 11.4.5 Danaher Recent Developments
  • 11.5 Merck KGaA
  • 11.5.1 Merck KGaA Company Details
  • 11.5.2 Merck KGaA Business Overview
  • 11.5.3 Merck KGaA EMEA Sterility Testing Introduction
  • 11.5.4 Merck KGaA Revenue in EMEA Sterility Testing Business (2017-2022)
  • 11.5.5 Merck KGaA Recent Developments
  • 11.6 Nelson Laboratories, LLC
  • 11.6.1 Nelson Laboratories, LLC Company Details
  • 11.6.2 Nelson Laboratories, LLC Business Overview
  • 11.6.3 Nelson Laboratories, LLC EMEA Sterility Testing Introduction
  • 11.6.4 Nelson Laboratories, LLC Revenue in EMEA Sterility Testing Business (2017-2022)
  • 11.6.5 Nelson Laboratories, LLC Recent Developments
  • 11.7 TOXICON
  • 11.7.1 TOXIKON Company Details
  • 11.7.2 TOXIKON Business Overview
  • 11.7.3 TOXIKON EMEA Sterility Testing Introduction
  • 11.7.4 TOXIKON Revenue in EMEA Sterility Testing Business (2017-2022)
  • 11.7.5 TOXIKON Recent Developments
  • 11.8 WuXiAppTec
  • 11.8.1 WuXiAppTec Company Details
  • 11.8.2 WuXiAppTec Business Overview
  • 11.8.3 WuXiAppTec EMEA Sterility Testing Introduction
  • 11.8.4 WuXiAppTec Revenue in EMEA Sterility Testing Business (2017-2022)
  • 11.8.5 WuXiAppTec Recent Developments
  • 11.9 Rapid Micro Biosystems, Inc.
  • 11.9.1 Rapid Micro Biosystems, Inc. Company Details
  • 11.9.2 Rapid Micro Biosystems, Inc. Business Overview
  • 11.9.3 Rapid Micro Biosystems, Inc. EMEA Sterility Testing Introduction
  • 11.9.4 Rapid Micro Biosystems, Inc. Revenue in EMEA Sterility Testing Business (2017-2022)
  • 11.9.5 Rapid Micro Biosystems, Inc. Recent Developments
  • 11.10 Baxter
  • 11.10.1 Baxter Company Details
  • 11.10.2 Baxter Business Overview
  • 11.10.3 Baxter EMEA Sterility Testing Introduction
  • 11.10.4 Baxter Revenue in EMEA Sterility Testing Business (2017-2022)
  • 11.10.5 Baxter Recent Developments
  • 11.11 Pace Analytical
  • 11.11.1 Pace Analytical Company Details
  • 11.11.2 Pace Analytical Business Overview
  • 11.11.3 Pace Analytical EMEA Sterility Testing Introduction
  • 11.11.4 Pace Analytical Revenue in EMEA Sterility Testing Business (2017-2022)
  • 11.11.5 Pace Analytical Recent Developments
  • 12 Analyst's Viewpoints/Conclusions

      13 Appendix

      • 13.1 Research Methodology
      • 13.1.1 Methodology/Research Approach
    • 13.1.2 Data Source
    • 13.2 Author Details
    • Summary:
      Get latest Market Research Reports on EMEA Sterility Testing. Industry analysis & Market Report on EMEA Sterility Testing is a syndicated market report, published as Global EMEA Sterility Testing Market Insights, Forecast to 2028. It is complete Research Study and Industry Analysis of EMEA Sterility Testing market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $4,350.00
      $8,700.00
      3,362.55
      6,725.10
      4,049.85
      8,099.70
      664,201.50
      1,328,403.00
      367,140.00
      734,280.00
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report